THE ROYAL PALACE – FRIDAY 6 SEPTEMBER
17.30
Baseline Patient Characteristics in ReITIrate – A Prospective Study of Rescue ITI with Recombinant Factor VIIIFc (rFVIIIFc) in Patients who Have Failed Previous ITI Attempts
C. Königs (Germany)
VIEW ePOSTER
17.40
Transplantation of fetal liver cells into newborn hemophilic mice for the treatment of hemophilia A without inhibitors formation
S. Merlin (Italy)
VIEW ePOSTER
17.50
LIFE-ACTIVE: observational study evaluating the physical activity in a subset of damoctocog alfa pegol treated Hemophilia A patients who are enrolled in the HEM-POWR study
E. Musi (Switzerland)
VIEW ePOSTER
18.00
Observational immune tolerance induction study (ObsITI): Immune tolerance induction with a single factor VIII/von Willebrand factor concentrate for treatment of haemophilia A patients with inhibitors
C. Escuriola (Spain)
VIEW ePOSTER
18.10
MOTIVATE: MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A – An international observational study
C. Escuriola (Germany)
VIEW ePOSTER
18.20
Structural Evidence of an Anti-Factor C1 Domain Antibody Bound to B Domain-Deleted Factor VIII
P.C. Spiegel (USA)
VIEW ePOSTER
THE ROYAL PALACE – SATURDAY 7 SEPTEMBER
18.30
Type 1 VWD caused by a novel dominant p.Thr274Pro mutation localized in VWF propeptide
L. Baronciani (Italy)
VIEW ePOSTER
18.40
Evaluation of the von Willebrand factor (VWF) inhibitor in a large cohort of European and Iranian patients previously diagnosed with type 3 von Willebrand disease (VWD) enrolled into the 3WINTER-IPS Project
L. Baronciani (Italy)
VIEW ePOSTER
18.50
Current view on the safety of PEGylated biologics in hemophilia treatment
Andreas Baumann (Germany)
VIEW ePOSTER
19.00
The presence of inhibitors against von Willebrand factor and factor VIII in the same patient: a case report
D. Coen Herak (Croatia)
VIEW ePOSTER
19.10
Evaluation of platelet-dependent VWF activity on a heterogeneous group of von Willebrand disease patients using four different methods: two VWF:GPIbM and two VWF:RCo assays
P. Colpani (Italy)
VIEW ePOSTER
